2015 Guidance on cancer immunotherapy development in early‐phase clinical studies

The development of cancer immunotherapies is progressing rapidly with a variety of technological approaches. They consist of “cancer vaccines”, which are based on the idea of vaccination, “effector cell therapy”, classified as passive immunotherapy, and “inhibition of immunosuppression”, which inten...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Sci
Главные авторы: Arato, Teruyo, Daimon, Takashi, Heike, Yuji, Ishii, Ken, Itho, Kyogo, Kageyama, Shinichi, Kawakami, Yutaka, Nakayama, Eiichi, Ozawa, Keiya, Sato, Noriyuki, Shiku, Hiroshi, Takeuchi, Masahiro, Tani, Kenzaburo, Tamada, Koji, Ueda, Ryuzo, Yamaguchi, Yoshiyuki, Yamanaka, Takeharu, Yamaue, Hiroki, Yasukawa, Masaki, Iguchi, Toyotaka, Kitano, Shigehisa, Miyahara, Yoshihiro, Nagata, Yasuhiro, Noguchi, Masanori, Terashima, Takeshi, Asano, Takeo, Asonuma, Motohiro, Ikeda, Hiroaki, Kakimi, Kazuhiro, Takesako, Kazutoh, Tanaka, Masanori, Amakasu, Kohei, Yamada, Akira, Harada, Naozumi, Aoshi, Taiki, Kuroda, Etsushi, Kobiyama, Kouji, Muraoka, Daisuke, Yamazaki, Naoya, Kuchiba, Aya, Tanaka, Shiro, Michimae, Hirofumi, Yamada, Tomomi, Hanada, Kenichi, Okada, Hideho, Takebe, Naoko, Hirano, Naoto, Okumura, Satoshi, Sato, Daisaku, Shibatsuji, Masayoshi, Yamaguchi, Teruhide
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2015
Предметы:
Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4714668/
https://ncbi.nlm.nih.gov/pubmed/26767933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12819
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы